Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma

Cancer Communications

Ying Guo¹  Ying Guan²  Wei-Wei Xiao³  Tai-Xiang Lu³  Chun-Yan Chen³  Fei Han³  Han-Yu Wang³  Chong Zhao³  Shuai Liu⁴ 

[1] Department of Clinical Trial, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medical, Guangzhou, P. R. China;Department of Radiation Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, Nanning, P. R. China;Department of Radiotherapy Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medical, Guangzhou, P. R. China;Department of Radiotherapy Oncology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China

关键词: Recurrence;    Nasopharyngeal carcinoma;    Intensity-modulated radiation therapy;    Concomitant chemoradiotherapy;    Cisplatin;   

DOI  :  10.1186/s40880-016-0081-7

学科分类：肿瘤学

来源: Springer

【 授权许可】

CC BY